Orasure Technologies Inc(OSUR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.69 | Insider Own | 6.61% | Shs Outstand | 69.0M | Perf Week | 2.17% |
| Market Cap | 0.24B | Forward P/E | - | EPS next Y | -2.48% | Insider Trans | 1.67% | Shs Float | 64.4M | Perf Month | -9.49% |
| Enterprise Value | 0.10B | PEG | - | EPS next Q | -0.17 | Inst Own | 85.21% | Short Float | 4.24% | Perf Quarter | -9.02% |
| Income | -0.05B | P/S | 2.17 | EPS this Y | 35.64% | Inst Trans | -2.23% | Short Ratio | 4.89 | Perf Half Y | 16.89% |
| Sales | 0.11B | P/B | 0.77 | EPS next 5Y | 21.77% | ROA | -12.2% | Short Interest | 2.73M | Perf YTD | 45.87% |
| Book/sh | 4.61 | P/C | 1.52 | EPS past 3/5Y | -58.18% -33.45% | ROE | -14.07% | 52W High | -22.93% ($4.58) | Perf Year | 47.39% |
| Cash/sh | 2.33 | P/FCF | - | Sales past 3/5Y | -33.29% -7.7% | ROIC | -14.75% | 52W Low | 69.71% ($2.08) | Perf 3Y | -43.16% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -0.63% | Gross Margin | 38.89% | Volatility(W/M) | 6.91% 5.71% | Perf 5Y | -63.46% |
| Dividend TTM | - | EV/Sales | 0.89 | Sales Y/Y TTM | -18.86% | Oper. Margin | -64.85% | ATR (14) | 0.22 | Perf 10Y | -53.98% |
| Dividend Ex-Date | - | Quick Ratio | 7.68 | EPS Q/Q | 133.72% | Profit Margin | -43.7% | RSI (14) | 43.48 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.88 | Sales Q/Q | -1.93% | SMA20 | -6.68% ($3.78) | Beta | 1.09 | Target Price | $5.5 |
| Payout | - | Debt/Eq | 0.05 | Earnings | 2026/11/9 | SMA50 | -5.27% ($3.73) | Rel Volume | 1.33 | Prev Close | $3.44 |
| Employees | 501 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | 7.32% -0.3% | SMA200 | -0.24% ($3.54) | Avg Volume(3M) | 0.56M | Price | $3.53 |
| IPO | 1986/11/17 | Option/Short | Yes/Yes | Trades | 3078 | Volume | 745,350 | Change | 2.62% |
🧪 OraSure Technologies is a U.S. medical device company that supplies rapid diagnostic tests based on oral fluid and sample collection/preservation solutions. It operates with two main pillars: the OraQuick line of tests, which quickly screen for HIV and Hepatitis C at the point of care, and sample collection devices for molecular diagnostics. These products are widely used by public health agencies, telehealth providers, and direct-to-consumer channels.
Over the past 1 year, roughly in the middle
23% below its 1-year high.
Traded more than usual. That is 133% of its average volume.
OSUR has a sound balance sheet but weak earning power
Of every $100 in sales, $64.85 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +35.6% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $217. Peers typically go for $269. Compared with its own 2-year average, it is 11% cheaper now.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -63.5%. The S&P 500 did +61% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 85.2%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #34 of 51 in the industry
Based on market cap of $243M.
EMBC#32 Embecta Corp $363M PER 4.3 
SMTI#33 Sanara MedTech Inc $295M PER - OSUR#34 Orasure Technologies Inc $243M PER - 
PDEX#35 Pro-Dex Inc $225M PER 19.2 
UTMD#36 Utah Medical Products Inc $208M PER 21.8 
FAQ
What kind of company is OSUR?
OSUR belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of OSUR?
The market cap of OSUR is approximately $243M, ranking 3,858 within its sector.
What is the 52-week high and low for OSUR?
OSUR has recorded a 52-week high of $4.58 and a low of $2.08.
